InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| EndotoxDetect™ - Colorimetric HEK-Blue™ LPS Detection Kit | A Synergy Between Endotoxin and (1→3)-Beta-D-Glucan Enhanced Neutrophil Extra... | 2021 | J Inflamm Res | Saithong S. et al. | DOI: 10.2147/JIR.S305225 |
| HEK-Blue™ hDectin-1b Cells | Continuous Exposure to Non-Soluble β-Glucans Induces Trained Immunity in M-CS... | 2021 | Front Immunol | Moerings B.G.J. et al. | DOI: 10.3389/fimmu.2021.672796 |
| HEK-Blue™ hDectin-1a Cells | Continuous Exposure to Non-Soluble β-Glucans Induces Trained Immunity in M-CS... | 2021 | Front Immunol | Moerings B.G.J. et al. | DOI: 10.3389/fimmu.2021.672796 |
| WGP - Whole Glucan Particles | Continuous Exposure to Non-Soluble β-Glucans Induces Trained Immunity in M-CS... | 2021 | Front Immunol | Moerings B.G.J. et al. | DOI: 10.3389/fimmu.2021.672796 |
| HEK-Blue™ Null1-v Cells | Continuous Exposure to Non-Soluble β-Glucans Induces Trained Immunity in M-CS... | 2021 | Front Immunol | Moerings B.G.J. et al. | DOI: 10.3389/fimmu.2021.672796 |
| QUANTI-Blue™ | Continuous Exposure to Non-Soluble β-Glucans Induces Trained Immunity in M-CS... | 2021 | Front Immunol | Moerings B.G.J. et al. | DOI: 10.3389/fimmu.2021.672796 |
| Zymosan | Continuous Exposure to Non-Soluble β-Glucans Induces Trained Immunity in M-CS... | 2021 | Front Immunol | Moerings B.G.J. et al. | DOI: 10.3389/fimmu.2021.672796 |
| Normocin® - Antimicrobial Reagent | Dectin-1-Mediated Production of Pro-Inflammatory Cytokines Induced by Yeast β... | 2021 | Front Immunol | Pedro A.R.V. et al. | DOI: 10.3389/fimmu.2021.689879 |
| WGP - Whole Glucan Particles | Dectin-1-Mediated Production of Pro-Inflammatory Cytokines Induced by Yeast β... | 2021 | Front Immunol | Pedro A.R.V. et al. | DOI: 10.3389/fimmu.2021.689879 |
| Puromycin | Dectin-1-Mediated Production of Pro-Inflammatory Cytokines Induced by Yeast β... | 2021 | Front Immunol | Pedro A.R.V. et al. | DOI: 10.3389/fimmu.2021.689879 |
| Zymosan | Dectin-1-Mediated Production of Pro-Inflammatory Cytokines Induced by Yeast β... | 2021 | Front Immunol | Pedro A.R.V. et al. | DOI: 10.3389/fimmu.2021.689879 |
| Pam3CSK4 | Dectin-1-Mediated Production of Pro-Inflammatory Cytokines Induced by Yeast β... | 2021 | Front Immunol | Pedro A.R.V. et al. | DOI: 10.3389/fimmu.2021.689879 |
| HEK-Blue™ hDectin-1b Cells | Dectin-1-Mediated Production of Pro-Inflammatory Cytokines Induced by Yeast β... | 2021 | Front Immunol | Pedro A.R.V. et al. | DOI: 10.3389/fimmu.2021.689879 |
| AddaVax™ | Immunogenicity of prime-boost protein subunit vaccine strategies against SARS... | 2021 | Nat Commun | Tan H.X. et al. | DOI: 10.1038/s41467-021-21665-8 |
| R848 (Resiquimod) | Self-guarding of MORC3 enables virulence factor-triggered immunity. | 2021 | Nature | Gaidt M.M. et al. | DOI: 10.1038/s41586-021-04054-5 |
| LPS-EB (LPS from E. coli O111:B4) | Self-guarding of MORC3 enables virulence factor-triggered immunity. | 2021 | Nature | Gaidt M.M. et al. | DOI: 10.1038/s41586-021-04054-5 |
| 5'ppp-dsRNA | Self-guarding of MORC3 enables virulence factor-triggered immunity. | 2021 | Nature | Gaidt M.M. et al. | DOI: 10.1038/s41586-021-04054-5 |
| 2'3'-cGAMP | Self-guarding of MORC3 enables virulence factor-triggered immunity. | 2021 | Nature | Gaidt M.M. et al. | DOI: 10.1038/s41586-021-04054-5 |
| Poly(I:C) (HMW) VacciGrade™ | Local, multimodal intralesional therapy renders distant brain metastases susc... | 2021 | Sci Rep | Yokoi T. et al. | DOI: 10.1038/s41598-021-01455-4 |
| THP1-Dual™ KO-MyD88 Cells | TNF leads to mtDNA release and cGAS/STING-dependent interferon responses that... | 2021 | Cell Rep | Willemsen J. et al. | DOI: 10.1016/j.celrep.2021.109977 |